Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy
Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (103)
- Volume 14, 2024 (2)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Latest articles:
- 5 records -
AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B
Zhang J, Zheng Y, Liu H, Liu B
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:17-30
Published Date: 24 March 2024
Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies
Malfona F, Testi AM, Chiaretti S, Moleti ML
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:1-15
Published Date: 13 March 2024
Polycythemia Vera: Barriers to and Strategies for Optimal Management
Duminuco A, Harrington P, Harrison C, Curto-Garcia N
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:77-90
Published Date: 21 December 2023
Zanubrutinib in Mantle Cell Lymphoma Management: A Comprehensive Review
Alsuhebany N, Pan C, Holovac E, Do B, McBride A
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:67-76
Published Date: 24 November 2023
90Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases
Wang J, Baidoun F, Tun HW, Alhaj Moustafa M
Blood and Lymphatic Cancer: Targets and Therapy 2023, 13:59-65
Published Date: 3 October 2023